Project Grant HT94252410648
- This $318,483 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports quantitative measurement of acute and chronic lesion activity in a real-world multisite clinical MRI dataset at The Johns Hopkins University. The research aims to transform healthcare for military service members, veterans, and the public through innovative biomedical research. The award period runs from August 1, 2025 to July 31, 2027. As a...
- The federal Project Grant award of $1,552,867.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The award supports advanced biomedical research focused on the early detection of endometrial carcinoma through cell enrichment and flow cytometry. The performance period runs from Sep 30, 2025 to Sep 29, 2028. As a leading federal research institution, Johns Hopkins has a demonstrated track record of...
- This $1,406,799 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research to develop real-time localization techniques using near-infrared fluorophores to guide robotic-assisted radical prostatectomy procedures. The 3-year award, running from August 1, 2024 to July 31, 2027, will enable Johns Hopkins to conduct innovative biomedical research to improve surgical outcomes and...
- The Johns Hopkins University has been awarded a $1,099,238 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) with a period of performance from September 1, 2024 to August 31, 2026. This grant will support investigator-initiated biomedical research projects across multiple medical disciplines to improve health outcomes for military service members, veterans, and the broader public. The award enables Johns Hopkins to conduct...
- This federal Project Grant award of $606,060.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Johns Hopkins University to engineer receptors to promote effective infiltration of CAR T cells into bladder tumors. The award, which runs from July 15, 2025 to July 14, 2027, aims to develop innovative medical solutions that address critical health challenges relevant to military personnel and civilian populations. As a leading...
- The federal Project Grant award of $610,059.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Johns Hopkins University to investigate "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The award period runs from July 1, 2025 to June 30, 2028 and aims to advance biomedical research focused on transforming healthcare for military service members, veterans, and the broader public....
- This Project Grant award of $320,165.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports biomedical research at The Johns Hopkins University focused on the social determinants of health, biological aging, and disease course in multiple sclerosis. The project aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions to critical health challenges. As a leading...
- The Johns Hopkins University was awarded a $1,228,125 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research titled "PSMA-TARGETED ACTIVATED MYELOID CELLS AS A NOVEL PROSTATE CANCER IMMUNOTHERAPY" from September 2021 through September 2024. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
- The Johns Hopkins University received a $459,932 Project Grant award on June 1, 2025 from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to conduct research titled "INTERROGATING CRIBRIFORM LESIONS TO UNCOVER MECHANISMS OF PROSTATE CANCER AGGRESSIVENESS AND METASTASIS". This grant award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project will...
- This $867,712 Project Grant award from the Department of the Army Medical Command (under the Military Medical Research and Development program, CFDA 12.420) supports advanced biomedical research at The Johns Hopkins University focused on transforming healthcare for military service members and the general public. The research aims to investigate effective treatment of pancreatic cancer through systemic chemotherapy combined with alpha-particle radiotherapy, with a focus on early hepatic...
This $484,013 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of "PSMA-TARGETED MULTIPARAMETRIC ULTRASOUND" research at The Johns Hopkins University. The award period runs from August 1, 2024 to July 31, 2026. The project aims to advance biomedical research and innovative medical solutions relevant to military personnel and the broader public. As a leading research institution, The Johns Hopkins University has a long history of delivering high-quality medical research, clinical trials, data analysis, and subject matter expertise to government agencies like the DoD, NIH, and CDC through prior federal contracts and grants. This award represents an opportunity for the university to further contribute its capabilities in areas such as public health, biomedical science, and defense medical solutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $484.0k | 7/17/24 |